Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional Pain is Associated with Functional Performance in People with Parkinson's Disease.

Journal of neurologic physical therapy : JNPT·2026
Same author

Integrated Microfluidic Platform for Longitudinal Imaging, Functional Assays, and Downstream Proteomics in C. elegans.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

OncoFlow: A multiplexed microfluidic platform for personalized drug sensitivity assessment.

New biotechnology·2025
Same author

Clinical Policy: Critical Issues in the Evaluation and Management of Adult Out-of-Hospital or Emergency Department Patients Presenting With Severe Agitation: Approved by the ACEP Board of Directors, October 6, 2023.

Annals of emergency medicine·2023
Same author

Evidence-based emergency department management of migraine and other primary headaches.

Emergency medicine practice·2023
Same author

Optimizing the fabrication of a 3D high-resolution implant for neural stimulation.

Journal of biological engineering·2023

Related Experiment Video

Updated: Jul 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

PTOLEMI: Personalized Cancer Treatment through Machine Learning-Enabled Image Analysis of Microfluidic Assays.

Bernard Moerdler1, Matan Krasner1, Elazar Orenbuch1

  • 1Life Sciences Faculty and Nanotechnology Institute, Bar-Ilan University, Ramat Gan 5290002, Israel.

Diagnostics (Basel, Switzerland)
|October 14, 2023
PubMed
Summary

This study introduces PTOLEMI, a Python-based system for rapid, accurate analysis of microfluidic cancer diagnostics. It enables personalized treatment insights at the point of care, overcoming traditional limitations.

Keywords:
image processingmachine learningmicrofluidicspoint of care diagnostics

More Related Videos

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

Related Experiment Videos

Last Updated: Jul 8, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
13:01

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment

Published on: June 3, 2022

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Computational Biology

Background:

  • Personalized cancer diagnostics face challenges with sample heterogeneity, manual analysis, and data processing limitations.
  • Current methods are time-intensive, costly, and hinder real-time, point-of-care interventions.
  • There is a need for automated, efficient, and accurate diagnostic tools for personalized cancer care.

Purpose of the Study:

  • To introduce PTOLEMI (Python-based Tensor Oncological Locator Examining Microfluidic Instruments), a novel system for high-throughput image analysis in microfluidic assays.
  • To demonstrate PTOLEMI's capability for rapid and accurate discrimination of cell viability and types in cancer patient samples.
  • To present an integrated framework for personalized drug screening and clinical decision-making.

Main Methods:

  • Development of PTOLEMI, a Python-based system integrating machine learning algorithms for image analysis.
  • Application of PTOLEMI to analyze cancer patient samples within a microfluidic apparatus.
  • Utilizing AI algorithms for rapid discrimination of cell viability and distinct cell types.

Main Results:

  • PTOLEMI enables high-throughput image analysis of microfluidic assays with speed and accuracy.
  • The system automates the diagnostic process, making it swift, precise, and resource-efficient.
  • PTOLEMI facilitates a granular understanding of cellular dynamics for targeted treatment options.

Conclusions:

  • PTOLEMI represents a significant advancement in point-of-care cancer diagnostics, overcoming traditional limitations.
  • The fusion of PTOLEMI with microfluidic platforms offers an integrated, rapid framework for personalized clinical decision-making.
  • This approach enhances personalized drug screening and therapeutic insights for cancer patients.